Pregabalin and venlafaxine improve symptoms of generalised anxiety disorder: Commentary

Evidence-Based Mental Health

Volumn 10, Issue 1, 2007, Pages 23-

  Stein, Dan J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47549117650     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.10.1.23     Document Type: Note

References (7)

1. Kessler RC. The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand Suppl 2000:7-13.
2. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2001;62:53-8. (Pubitemid 32537578)
3. Kapczinski F, Lima MS, Souza JS, et al. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003;CD003592.
4. Goodwin RM, Gorman JM. Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. Am J Psychiatry 2002;159:1935-7. (Pubitemid 35283264)
5. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50:884-95.
6. Bielski RJ, Bose A, Chang CC. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder. Ann Clin Psychiatry 2005;17:65-9. (Pubitemid 40967128)
7. Baldwin DS, Huusom AKT, Maehlum E. Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. Br J Psychiatry 2006;189:264-72. (Pubitemid 44343473)